HC Wainwright Trims Ovid Therapeutics (NASDAQ:OVID) Target Price to $3.00
Ovid Therapeutics (NASDAQ:OVID – Free Report) had its target price trimmed by HC Wainwright from $9.00 to $3.00 in a research note published on Tuesday, Benzinga reports. The brokerage currently has a buy rating on the stock. Other analysts have also issued reports about the stock. B. Riley initiated coverage on shares of Ovid Therapeutics […]
More Stories
Critical Survey: International Container Terminal Services (OTCMKTS:ICTEF) & Navios Maritime Partners (NYSE:NMM)
Navios Maritime Partners (NYSE:NMM – Get Free Report) and International Container Terminal Services (OTCMKTS:ICTEF – Get Free Report) are both...
Reviewing AngioDynamics (NASDAQ:ANGO) & Gerresheimer (OTCMKTS:GRRMF)
Gerresheimer (OTCMKTS:GRRMF – Get Free Report) and AngioDynamics (NASDAQ:ANGO – Get Free Report) are both medical companies, but which is...
Citigroup Begins Coverage on Kodiak Gas Services (NYSE:KGS)
Citigroup started coverage on shares of Kodiak Gas Services (NYSE:KGS – Free Report) in a report issued on Friday morning,...
Jabil (NYSE:JBL) Price Target Increased to $140.00 by Analysts at Stifel Nicolaus
Jabil (NYSE:JBL – Free Report) had its price objective increased by Stifel Nicolaus from $130.00 to $140.00 in a research...
Kinsale Capital Group (NYSE:KNSL) PT Raised to $530.00 at Truist Financial
Kinsale Capital Group (NYSE:KNSL – Free Report) had its price target hoisted by Truist Financial from $485.00 to $530.00 in...
Head-To-Head Review: NETGEAR (NASDAQ:NTGR) and TPT Global Tech (OTCMKTS:TPTW)
TPT Global Tech (OTCMKTS:TPTW – Get Free Report) and NETGEAR (NASDAQ:NTGR – Get Free Report) are both computer and technology...